HK1151241A1 - 治療性蛋白質的功效的增強 - Google Patents
治療性蛋白質的功效的增強Info
- Publication number
- HK1151241A1 HK1151241A1 HK11105410.8A HK11105410A HK1151241A1 HK 1151241 A1 HK1151241 A1 HK 1151241A1 HK 11105410 A HK11105410 A HK 11105410A HK 1151241 A1 HK1151241 A1 HK 1151241A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- enhancement
- efficacy
- therapeutic proteins
- proteins
- therapeutic
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ZA200705497 | 2007-07-05 | ||
PCT/IB2008/052692 WO2009004595A2 (en) | 2007-07-05 | 2008-07-04 | Enhancement of the efficacy of therapeutic proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1151241A1 true HK1151241A1 (zh) | 2012-01-27 |
Family
ID=40032617
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK11105410.8A HK1151241A1 (zh) | 2007-07-05 | 2011-05-31 | 治療性蛋白質的功效的增強 |
Country Status (7)
Country | Link |
---|---|
US (4) | US20100297249A1 (zh) |
EP (1) | EP2194970B1 (zh) |
JP (1) | JP5563450B2 (zh) |
CN (1) | CN101951888B (zh) |
HK (1) | HK1151241A1 (zh) |
WO (1) | WO2009004595A2 (zh) |
ZA (1) | ZA200908989B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101633919B (zh) * | 2009-08-17 | 2013-04-24 | 浙江工业大学 | 不饱和脂肪酸-Cu/Zn-超氧化物歧化酶修饰物及其制备 |
US10363324B2 (en) * | 2013-11-04 | 2019-07-30 | The South African Nuclear Energy Corporation Limited | Pharmaceutical composition |
US10610546B2 (en) | 2015-05-13 | 2020-04-07 | Synlogic Operating Company Inc. | Bacteria engineered to reduce hyperphenylalaninemia |
AU2016356684C1 (en) * | 2015-11-16 | 2022-11-10 | Synlogic Operating Company, Inc. | Bacteria engineered to reduce hyperphenylalaninemia |
EP3642221A1 (en) | 2017-06-21 | 2020-04-29 | Synlogic Operating Company, Inc. | Bacteria for the treatment of disorders |
US11358994B2 (en) | 2017-07-27 | 2022-06-14 | Saint Louis University | Fatty acid modified human epidermal growth factor |
CN115298308A (zh) | 2020-03-20 | 2022-11-04 | 同生运营公司 | 经工程化以减轻高苯丙氨酸血症的微生物 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5257313A (en) * | 1975-11-07 | 1977-05-11 | Yamanouchi Pharmaceut Co Ltd | Manufacture of micellar insuline emulsion preparations |
JPS5517328A (en) * | 1978-07-21 | 1980-02-06 | Tanabe Seiyaku Co Ltd | Insulin-containing emulsion and its preparation |
DE4208552A1 (de) * | 1992-03-17 | 1993-09-23 | Liedtke Pharmed Gmbh | Topische arzneiformen mit insulin |
ATE334689T1 (de) * | 1995-11-13 | 2006-08-15 | Univ Northwest | Verabreichungsmedium für analgetische, entzündungshemmende und antipyretische wirkstoffe und pharmazeutische zusammensetzungen enthaltend solches medium und wirkstoffe |
JPH10330287A (ja) * | 1997-03-31 | 1998-12-15 | Nippon Suisan Kaisha Ltd | 多価不飽和脂肪酸からなる消化管吸収促進剤およびそれを含有する薬剤 |
US20020039594A1 (en) * | 1997-05-13 | 2002-04-04 | Evan C. Unger | Solid porous matrices and methods of making and using the same |
US6271200B1 (en) * | 1998-12-21 | 2001-08-07 | Generex Pharmaceuticals Inc. | Proteinic drug delivery system using aerosolized membrane-mimetic amphiphiles |
DK1476171T3 (da) * | 2000-07-19 | 2011-01-10 | Univ Northwest | Transport af nukleinsyresubstanser |
CA2416512C (en) * | 2000-07-19 | 2010-10-19 | Pitmy International N.V. | Enhancement of the action of anti-infective agents |
EP1843787B1 (en) * | 2005-01-28 | 2011-11-02 | North-West University | Lipid and nitrous oxide combination as adjuvant for the enhancement of the efficacy of vaccines |
CN101426369A (zh) * | 2006-02-27 | 2009-05-06 | 西北大学 | 含有游离脂肪酸和/或游离脂肪酸衍生物的微乳液形式组合物 |
-
2007
- 2007-07-05 US US12/667,722 patent/US20100297249A1/en not_active Abandoned
-
2008
- 2008-07-04 EP EP08789190.9A patent/EP2194970B1/en not_active Not-in-force
- 2008-07-04 CN CN200880101395.7A patent/CN101951888B/zh not_active Expired - Fee Related
- 2008-07-04 JP JP2010514237A patent/JP5563450B2/ja not_active Expired - Fee Related
- 2008-07-04 WO PCT/IB2008/052692 patent/WO2009004595A2/en active Application Filing
-
2009
- 2009-12-17 ZA ZA2009/08989A patent/ZA200908989B/en unknown
-
2011
- 2011-05-31 HK HK11105410.8A patent/HK1151241A1/zh not_active IP Right Cessation
-
2013
- 2013-08-26 US US13/975,816 patent/US20130344157A1/en not_active Abandoned
-
2014
- 2014-05-20 US US14/282,256 patent/US20140255504A1/en not_active Abandoned
-
2019
- 2019-12-13 US US16/713,232 patent/US20200114007A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP5563450B2 (ja) | 2014-07-30 |
EP2194970A2 (en) | 2010-06-16 |
EP2194970B1 (en) | 2015-09-02 |
US20200114007A1 (en) | 2020-04-16 |
WO2009004595A2 (en) | 2009-01-08 |
CN101951888B (zh) | 2014-06-04 |
ZA200908989B (en) | 2011-03-30 |
US20100297249A1 (en) | 2010-11-25 |
WO2009004595A3 (en) | 2011-01-20 |
CN101951888A (zh) | 2011-01-19 |
JP2010532343A (ja) | 2010-10-07 |
US20140255504A1 (en) | 2014-09-11 |
US20130344157A1 (en) | 2013-12-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1211889A1 (zh) | 二氨基吩噻嗪的治療用途 | |
BR112012004546A2 (pt) | "terapêutica por proteínas ligantes dll4-ligantes" | |
EP2117311A4 (en) | THERAPEUTICS | |
EP2068864A4 (en) | THERAPEUTIC USES OF UROLITHINS | |
GB0602178D0 (en) | Therapeutic treatment | |
GB0609492D0 (en) | Therapeutic agents | |
GB0608928D0 (en) | Therapeutic agents | |
GB0601962D0 (en) | Therapeutic agents | |
HRP20130041T8 (en) | Therapeutic agents | |
GB0616214D0 (en) | Therapeutic Agents | |
HK1244426A1 (zh) | 治療性蛋白質製劑 | |
IL200761A0 (en) | Body massager | |
GB0608655D0 (en) | Therapeutic Treatment | |
GB0723747D0 (en) | Therapeutic agents | |
GB0611152D0 (en) | Therapeutic agents | |
HK1151241A1 (zh) | 治療性蛋白質的功效的增強 | |
GB0724340D0 (en) | Novel Therapeutic Agents | |
GB0610909D0 (en) | Therapeutic treatment | |
GB0620059D0 (en) | Therapeutic agents | |
GB0609121D0 (en) | Peptide Therapy | |
GB0609676D0 (en) | Therapeutic agents | |
GB0723748D0 (en) | Therapeutic agents | |
GB0602857D0 (en) | The treatment of sialorrhoea | |
GB0610376D0 (en) | Therapeutic treatment | |
GB0711465D0 (en) | Silan-3-amines and disilan-5-amines as therapeutic agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20210701 |